Pancragen Peptide 99%

Pancragen Peptide 99%
Details:
CAS: N/A
MF/MW: C26H36N6O9/576.25
Sequence: Lys-Glu-Asp-Trp (KEDW)
Purity: NLT 99%
Appearance: White powder
Specifications: Raw powder or vials form
Solubility: Easily dissolves in water
Customization Service: Raw powder or custom vial filling; vial size, fill weight, labels, and batch documents can be discussed.
Send Inquiry
Description
Send Inquiry
product-768-512

Pancragen Peptide 99% is a tetrapeptide composed of the amino acid sequence Lys-Glu-Asp-Trp (KEDW). It is a synthetic analog derived from a peptide originally isolated from bovine pancreatic cells and has been identified as a potential peptide bioregulator with implications for pancreatic function and age-associated metabolic processes. Aimed at supporting pancreatic function, pancragen can interact with histones and DNA, potentially improving glucose metabolism and insulin production. It may also aid in tissue repair within the pancreas.However, its biological effects remain largely theory-driven and should be interpreted in the context of limited high-level clinical evidence.

Shaanxi Medibridge for high-quality research-grade Pancragen Peptide 99%. As a specialized peptide supplier, we provide lyophilized powder with ≥99% purity verified by HPLC, supported by lot-specific COA, MS/HPLC analytical data, and rigorous impurity control. Our products are available in quantities ranging from milligrams to bulk scale, with custom packaging options and fast worldwide shipping.

COA

product-818-136

Product Name

CAS Number

Batch Number

Pancragen Peptide 99%

N/A

MB2601262256

Manufacturer Date

Analysis Date

Expiry Date

2026/2/29

2026/2/30

2028/2/28

Sample Qty Base

Packing

Test Method

5.36KGS

10GS/bottle

HPLC

Item

Standard

Results

Appearance

White lyophilized peptide powder

Conforms

Identification (HPLC)

Retention time consistent with reference standard

Conforms

Peptide Sequence

Lys-Glu-Asp-Trp (KEDW)

Conforms

Molecular Formula

C26H36N6O9

Conforms

Molecular Weight

576.25

Conforms

Purity (HPLC)

NLT 98.0%

98.75%

Solubility

Soluble in water

Conforms

Water Content (Karl Fischer)

NMT 5.0%

2.33%

Acetate Content

NMT 12.0%

6.41%

Heavy Metals

NMT 10 ppm

Conforms

Related Substances

NMT 2.0%

Conforms

Microbial Limits

Complies with laboratory reagent standards

Conforms

Storage

Store in cool & dry place. keep away from strong light and heat

Conclusion

The batch conforms to the IN-HOUSE standard

product-770-136

Specification(for research use only)

Form

Sample Order

Specification

Raw powder

1 g

Purity is NLT 99%

Vials

10 vials

3ml/5ml/7ml/15ml vials etc.

Structural Characteristics

Pancragen is a tetrapeptide composed of the sequence Lys–Glu–Asp–Trp (KEDW). Its structure includes one basic residue (Lys), two acidic residues (Glu and Asp), and one aromatic residue (Trp). This composition gives the peptide a chemically varied character, which may underlie its distinctive charge properties, polarity, and capacity to interact with biomolecules such as proteins, chromatin-related structures, and other regulatory cellular components.

From a molecular perspective, this combination may affect:

  • Charge distribution
  • Interaction tendency with protein/chromatin components
  • Solubility and microenvironment adaptability
  • Binding potential with nucleic acid or nucleoprotein complexes
product-1536-1024

Pancreatic Function

product-768-512

Pancragen has been studied for its potential to support pancreatic endocrine function by influencing cellular differentiation and hormone-related activity. Experimental findings suggest that it may enter cells, interact with nuclear components, and regulate transcription factors involved in pancreatic development, thereby promoting acinar and islet cell maturation.

Preclinical studies suggest that Pancragen may help improve pancreatic morphology and functional balance under metabolically impaired conditions. In murine diabetes and cell-based models, it was associated with stronger β-cell support, reduced α-cell dominance, normalized proliferative and apoptotic activity, and improved markers of pancreatic cell viability.

Effects on Cellular Aging

Pancragen has been studied for its potential effects on cellular aging, especially in pancreatic and metabolic models. Experimental findings suggest that it may reduce apoptotic and aging-related markers such as caspase-3, cathepsin B, and TNF-α, while increasing IGF-I. It has also been associated with improved glucose regulation and possible effects on age-related gene methylation and expression.

product-1536-1024

Cellular Protection

product-1536-1024

Pancragen has been examined for its possible cytoprotective effects during cellular stress. Current findings indicate that it may lessen oxidative injury by reducing free radical activity and supporting endogenous antioxidant defenses. It has also been linked to modulation of inflammatory signaling, with lower levels of pro-inflammatory cytokines and enhanced anti-inflammatory responses. Together, these effects may help preserve cellular integrity and maintain functional stability under conditions of oxidative or inflammatory stress.

Scientific Hypothesis

Nuclear Regulatory Hypothesis

Pancragen is proposed to enter cells, localize to the nucleus, and interact with DNA regulatory regions or histone-associated structures. If confirmed, this would suggest a mechanism closer to transcriptional modulation than to conventional membrane receptor activation.

Protein Synthesis and Cellular Support

Pancragen may support pancreatic cellular activity by influencing gene expression and protein synthesis. This proposed effect has been associated with metabolic activity, cellular repair capacity, maintenance of tissue homeostasis, and partial attenuation of age-related functional decline.

Pancreatic Metabolic Relevance

Research on Pancragen often emphasizes its potential relationship with pancreatic metabolism, including support for glucose regulation, insulin secretion, maintenance of β-cell function, and pancreatic tissue repair under conditions of functional stress or decline.

product-1024-1536

Compared With Mainstream peptide drugs

Dimension

Pancragen-Type Bioregulators

Western Peptide Drugs

Origin

Organ-related or biomimetic short peptides

Rationally designed or engineered peptides

Length

Usually short

Short or long

Mechanism

Multi-level regulation, proposed nuclear effects

Clearer receptor targets

Action

Functional support or modulation

Agonist or antagonist effects

Evidence

Often observational or regional studies

More RCT-based evidence

Clinical Use

Varies by region

More widely included in guidelines

Research Direction

From a research perspective, Pancragen may be involved in the following areas:

Pancreatic Function Research

As a short peptide material related to the pancreas, it can be used to observe its effects on:

  • Pancreatic cell activity
  • Endocrine secretion behavior
  • Tissue morphological changes
  • Post-injury repair processes

Glucose Metabolism and Age-Related Metabolic Research

Because the pancreas plays a central role in glucose homeostasis, Pancragen is often discussed in the following research contexts:

  • Age-related metabolic imbalances
  • Changes in glucose tolerance
  • Impaired pancreatic function
  • Models related to metabolic syndrome

Comparative Studies of Bioregulatory Peptides

Pancragen can also serve as a representative of organ-specific bioregulatory peptides, used for comparison with other short peptides, for example, comparing their differences in:

  • Different tissue targeting theories
  • Gene expression influence patterns
  • Tissue support effects in aging models

FAQ

What does pancragen peptide do?

Pancragen is a synthetic tetrapeptide designed to support pancreatic function and regulate cellular metabolic processes.

What peptide helps the pancreas?

Peptides for pancreas health primarily target insulin production, glucose regulation, and cellular regeneration.

Can we live without a pancreas?

Yes, you can live without a pancreas, but it requires lifelong medical treatment to replace the hormones and enzymes the organ normally makes.

What is Pancreatin derived from?

Pancreatin is a mixture of digestive enzymes used to treat conditions like cystic fibrosis or pancreatitis.

Does pancreatin contain pork?

Pancreatin contains various enzymes having proteolytic, lipolytic and amylolytic activity.

 

Hot Tags: pancragen peptide 99%, China pancragen peptide 99% manufacturers, suppliers, factory, chonluten peptide active ingredient, cortagen peptide drug substance, ovagen peptide preparation powder, ovagen peptide substance, respiratory formula powder, vilon peptide powder

Send Inquiry